Related Experiment Videos
Evaluation of forequarter amputation in malignant diseases
Summary
Forequarter amputation for cancer offers palliative relief but has a low 5-year survival rate for curative intent. This procedure is not recommended for recurrent malignant melanoma due to poor outcomes.
Area of Science:
- Surgical Oncology
- Cancer Treatment
- Orthopedic Oncology
Background:
- Forequarter amputation is a radical surgical procedure for advanced upper limb malignancies.
- Indications include soft tissue sarcoma, osteosarcoma, and certain carcinomas.
- The psychological impact and survival outcomes require careful consideration.
Purpose of the Study:
- To evaluate the efficacy and survival outcomes of forequarter amputation for various upper extremity cancers.
- To assess the palliative benefits and limitations of the procedure.
- To identify prognostic factors influencing survival and recurrence.
Main Methods:
- Retrospective analysis of 21 forequarter amputations performed over 15 years.
- Data collected on tumor type, patient demographics, treatment intent (curative vs. palliative), and survival.
- Analysis of recurrence patterns and survival rates based on malignancy type.
Main Results:
- Overall 5-year survival for curative intent was 25%.
- No 5-year survivors were observed for unclassified sarcoma, myosarcoma, or recurrent malignant melanoma.
- Two patients with recurrent breast carcinoma experienced significant palliative relief.
Conclusions:
- Forequarter amputation is not recommended for recurrent malignant melanoma, but can be palliative.
- Early detection of metastasis is crucial before considering this procedure for poor-prognosis tumors.
- Adjuvant therapies are recommended for patients with a poor prognosis to improve survival outcomes.